The Potential Mechanism of Soy Isoflavones in Treating Osteoporosis: Focusing on Bone Metabolism and Oxidative Stress
Yuanyuan Zhou,
No information about this author
Zhan Su,
No information about this author
Gang Liu
No information about this author
et al.
Phytotherapy Research,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 8, 2025
Osteoporosis
is
divided
into
primary
and
secondary
types.
Primary
osteoporosis
may
result
from
estrogen
deficiency
in
postmenopausal
women,
imbalanced
bone
remodeling
the
elderly,
or
adolescent-type
development.
Secondary
can
be
caused
by
factors
like
long-term
glucocorticoid
treatment,
chronic
kidney
disease
(CKD),
deprivation,
oxidative
stress,
diabetes,
obesity.
This
review
focuses
on
therapeutic
potential
of
soy
isoflavones
for
osteoporosis.
At
cellular
level,
isoflavones,
as
natural
plant
extracts
phytoestrogens,
are
crucial
osteoblastogenesis
differentiation,
osteoclastogenesis,
osteoclast
mineralization,
marrow
mesenchymal
stromal
cell
differentiation.
They
also
maintain
calcium
homeostasis
regulating
extracellular
vitamin
D
levels.
In
terms
mitigate
it
endoplasmic
reticulum
mitochondria,
thus
senescence,
autophagy,
processes.
Moreover,
relieve
symptoms
related
to
CKD
inhibit
secretion,
which
directly
indirectly
benefits
treatment
Overall,
have
treat
enhancing
health,
metabolism,
alleviating
stress.
Future
research
should
explore
phytoestrogens
treating
exploration
focus
clarifying
safety,
identifying
side
effects,
determining
optimal
dosage
regimen,
developing
strategies
any
adverse
reactions.
addition,
further
large-scale,
multicenter
human
clinical
trials
necessary
accurately
evaluate
actual
effect
Language: Английский
Association of nuclear magnetic resonance-based metabolomics with bone health in the UK Biobank
Bone,
Journal Year:
2025,
Volume and Issue:
unknown, P. 117460 - 117460
Published: March 1, 2025
Language: Английский
Atherogenic index of plasma is associated with vertebral fracture: a longitudinal study
Xin Zhang,
No information about this author
Pinliang Xie,
No information about this author
Yong Yin
No information about this author
et al.
Frontiers in Endocrinology,
Journal Year:
2025,
Volume and Issue:
16
Published: May 28, 2025
Purpose
The
atherogenic
index
of
plasma
(AIP),
recognized
as
a
marker
atherosclerosis,
which
also
has
profound
impact
on
bone
metabolism.
However,
research
exploring
the
association
between
AIP
and
probability
vertebral
fractures
in
populations
is
still
relatively
scarce.
study
aims
to
evaluate
individuals
longitudinal
study.
Patients
methods
A
total
1395
subjects
who
were
older
than
55
years
underwent
CT
scans
for
lung
cancer
screening
July
2019
2021
enrolled
followed
up
duration
ranging
from
8
months
6
years.
Among
them,
91
experienced
new
fractures.
Participants
stratified
into
four
groups
based
quartiles.
was
then
assessed
by
cox
proportional
hazards
model.
Results
incidence
fracture
decreased
with
increasing
(p
trend
=
0.001).
Kaplan-Meier
survival
analysis
indicated
that
more
likely
occur
patients
low
levels
(log-rank,
all
P
<
0.05).
Multivariate
Cox
regression
showed
negatively
associated
even
after
accounting
confounding
factors
(adjusted
hazard
ratio
(aHR)
0.27,
95%CI
0.10-0.71
continuous
AIP;
aHR
0.48,
0.26-0.90
Q2;
0.41,
0.19-0.88
Q4,
respectively).
Subgroup
such
associations
mainly
observed
male
subjects.
Restricted
cubic
splines
further
adjusting
confounders
overall
population
men,
but
not
women.
Conclusion
Our
demonstrated
strong
fracture.
Low
may
be
an
factor
Language: Английский